The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis
Global tuberculosis incidence has declined marginally over the past decade, and
tuberculosis remains out of control in several parts of the world including Africa and Asia …
tuberculosis remains out of control in several parts of the world including Africa and Asia …
Treatment of tuberculosis
CR Horsburgh Jr, CE Barry III… - New England Journal of …, 2015 - Mass Medical Soc
Treatment of Tuberculosis | New England Journal of Medicine Skip to main content The New
England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES Cardiology …
England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES Cardiology …
Official American thoracic society/centers for disease control and prevention/infectious diseases society of America clinical practice guidelines: treatment of drug …
P Nahid, SE Dorman, N Alipanah… - Clinical infectious …, 2016 - academic.oup.com
Abstract The American Thoracic Society, Centers for Disease Control and Prevention, and
Infectious Diseases Society of America jointly sponsored the development of this guideline …
Infectious Diseases Society of America jointly sponsored the development of this guideline …
Therapeutic drug monitoring in the treatment of tuberculosis: an update
A Alsultan, CA Peloquin - Drugs, 2014 - Springer
Tuberculosis (TB) is the world's second leading infectious killer. Cases of multidrug-resistant
(MDR-TB) and extremely drug-resistant (XDR-TB) have increased globally. Therapeutic …
(MDR-TB) and extremely drug-resistant (XDR-TB) have increased globally. Therapeutic …
A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis
Rationale: Rifampin at a dose of 10 mg/kg was introduced in 1971 based on
pharmacokinetic, toxicity, and cost considerations. Available data in mice and humans …
pharmacokinetic, toxicity, and cost considerations. Available data in mice and humans …
Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement
The emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR)
tuberculosis (TB) substantially challenges TB control, especially in the European Region of …
tuberculosis (TB) substantially challenges TB control, especially in the European Region of …
[HTML][HTML] The role of whole genome sequencing in antimicrobial susceptibility testing of bacteria: report from the EUCAST Subcommittee
MJ Ellington, O Ekelund, FM Aarestrup… - Clinical microbiology …, 2017 - Elsevier
Whole genome sequencing (WGS) offers the potential to predict antimicrobial susceptibility
from a single assay. The European Committee on Antimicrobial Susceptibility Testing …
from a single assay. The European Committee on Antimicrobial Susceptibility Testing …
[HTML][HTML] Mycobacterium tuberculosis drug-resistance testing: challenges, recent developments and perspectives
Drug-resistance testing, or antimicrobial susceptibility testing (AST), is mandatory for
Mycobacterium tuberculosis in cases of failure on standard therapy. We reviewed the …
Mycobacterium tuberculosis in cases of failure on standard therapy. We reviewed the …
Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis
Extensively drug-resistant tuberculosis is a burgeoning global health crisis mainly affecting
economically active young adults, and has high mortality irrespective of HIV status. In some …
economically active young adults, and has high mortality irrespective of HIV status. In some …
Food for thought: addressing undernutrition to end tuberculosis
P Sinha, K Lönnroth, A Bhargava… - The Lancet Infectious …, 2021 - thelancet.com
Tuberculosis is the leading cause of deaths from an infectious disease worldwide. WHO's
End TB Strategy is falling short of several 2020 targets. Undernutrition is the leading …
End TB Strategy is falling short of several 2020 targets. Undernutrition is the leading …